Cryotomy in a Mohs service: the Welsh experience

Pioneered in the 1930s in the USA by Dr Frederic Mohs (1910–2002), Mohs micrographic surgery is a highly effective means of treating certain types of primary skin cancer, most commonly basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). These occur most frequently on the head and neck, with clinically invisible microscopic extensions, or situated on critical anatomical structures such as the nose, eyelid, lip or ear. It is vital to remove all the tumour to prevent recurrence, yet also desirable to minimise loss of normal skin tissue to avoid cosmetically unsightly wounds. The Thermo Scientific Cryostar cryostat can help to optimise workflow and throughput in the modern Mohs clinic, enabling more patients to be seen per clinic session.

This story is Premium Content and is only available to registered users. If you don't already have an account, please register with us completely free of charge.

Other news

Upcoming Events

Lab Innovations 2018

NEC, Birmingham
31 October - 1 November 2018

Latest Issue

Pathology In Practice

Pathology In Practice

Oct 2018

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.